The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells

Nature Immunology

Volumn 7, Issue 5, 2006, Pages 475-481

  Hamilton, Sara E ^a   Wolkers, Monika C ^b   Schoenberger, Stephen P ^b   Jameson, Stephen C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HOMEOSTASIS; IMMUNOLOGIC MEMORY; LISTERIA INFECTIONS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646016305     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1326     Document Type: Article

References (44)

1. Masopust, D., Kaech, S.M., Wherry, E.J. & Ahmed, R. The role of programming in memory T-cell development. Curr. Opin. Immunol. 16, 217-225 (2004).
2. + T cell response to infection. Curr. Opin. Immunol. 14, 360-365 (2002).
3. Bourgeois, C., Veiga-Fernandes, H., Joret, A.M., Rocha, B. & Tanchot, C. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32, 2199-2207 (2002).
4. + T cell memory. Science 297, 2060-2063 (2002).
5. + T lymphocytes. Nature 421, 852-856 (2003).
6. Shedlock, D.J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337-339 (2003).
7. Sun, J.C. & Bevan, M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300, 339-342 (2003).
8. + T cells after acute infection. Nat. Immunol. 5, 927-933 (2004).
9. Ernst, B., Lee, D.-S., Chang, J.M., Sprent, J. & Surh, C.D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11, 173-181 (1999).
10. + T cells in lymphopenic hosts. Immunity 11, 183-190 (1999).
11. Cho, B.K., Rao, V. P., Ge, Q., Eisen, H.N. & Chen, J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192, 549-556 (2000).
12. Goldrath, A.W., Luckey, C.J., Park, R., Benoist, C. & Mathis, D. The molecular program induced in T cells undergoing homeostatic proliferation. Proc. Natl. Acad. Sci. USA 101, 16885-16890 (2004).
13. Stockinger, B., Kassiotis, G. & Bourgeois, C. Homeostasis and T cell regulation. Curr. Opin. Immunol. 16, 775-779 (2004).
14. Marleau, A.M. & Sarvetnick, N. T cell homeostasis in tolerance and immunity. J. Leukoc. Biol. 78, 575-584 (2005).
15. + T cells. Nat. Immunol. 1, 107-111 (2000).
16. Almeida, A.R., Rocha, B., Freitas, A.A. & Tanchot, C. Homeostasis of T cell numbers: From thymus production to peripheral compartmentalization and the indexation of regulatory T cells. Semin. Immunol. 17, 239-249 (2005).
17. Prlic, M., Blazar, B.R., Khoruts, A., Zell, T. & Jameson, S.C. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167, 5664-5668 (2001).
18. Hagen, K.A. et al. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells. J. Immunol. 173, 3909-3915 (2004).
19. Dudley, M.E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854 (2002).
20. Hu, H.-M., Poehlein, C.H., Urba, W.J. & Fox, B.A. Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res. 62, 3914-3919 (2002).
21. Durnmer, W. et al. T cell homeostatic proliferation elicits effective anti-tumor autoimmunity. J. Clin. Invest. 110, 185-192 (2002).
22. Wrzesinski, C. & Restifo, N.P. Less is more: Lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy. Curr. Opin. Immunol. 17, 195-201 (2005).
23. Opferman, J.T., Ober, B.T. & Ashton-Rickardt, P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283, 1745-1748 (1999).
24. Wherry, E.J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234 (2003).
25. Kaech, S.M., Hemby, S., Kersh, E. & Ahmed, R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837-851 (2002).
26. Kieper, W.C. & Jameson, S.C. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96, 13306-13311 (1999).
27. Goldrath, A.W., Bogatzki, L.Y. & Bevan, M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192, 557-564 (2000).
28. Murali-Krishna, K. & Ahmed, R. Cutting edge: Naive T cells masquerading as memory cells. J. Immunol. 165, 1733-1737 (2000).
29. Kieper, W.C., Prlic, M., Schmidt, C.S., Mescher, M.F. & Jameson, S.C. IL-12 enhances CD8 T cell homeostatic expansion. J. Immunol. 166, 5515-5521 (2001).
30. Oehen, S. & Brduscha-Riem, K. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies? Eur. J. Immunol. 29, 608-614 (1999).
31. + lymphocytes convert to anergic or memory-like cells in T cell-deprived recipients. Eur. J. Immunol. 31, 2256-2265 (2001).
32. + suppressor T cells in vivo. Nat. Immunol. 3, 33-41 (2002).
33. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434, 88-93 (2005).
34. Pope, C. et al. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166, 3402-3409 (2001).
35. + T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198, 1583-1593 (2003).
36. + T cells in major histocompatibility complex class II-deficient mice. Science 253, 1417-1420 (1991).
37. Di Pietro, R. & Zauli, G. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J. Cell. Physiol. 201, 331-340 (2004).
38. Diehl, G.E. et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21, 877-889 (2004).
39. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18, 275-308 (2000).
40. Zheng, S.J., Jiang, J., Shen, H. & Chen, Y.H. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J. Immunol. 173, 5652-5658 (2004).
41. Hogquist, K.A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
42. Cretney, E. et al. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168, 1356-1361 (2002).
43. Bishop, D.K. & Hinrichs, D.J. Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements. J. Immunol. 139, 2005-2009 (1987).
44. Daniels, M.A. & Jameson, S.C. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191, 335-346 (2000).